
Photo by Innerbody Research
Welcome to the Club for Folks Who Have Heard About Peptides, Aren’t Really That Acquainted, But Want to Learn More. It’s a rapidly growing club, especially since the March 2026 announcement of a mass peptide “unbanning” and the steps forward in April to lift restrictions on 12 specific peptide treatments.1 14 Your Ozempics, Wegovys, and other mainstream GLP-1s aren’t the focus here. Rather, it’s the much broader array of prescription treatments unrelated to weight loss we’re talking about. There are a lot of them, many of which we've written about, that offer benefits for muscle mass, recovery, cognition, immunity, and more.
The lingering question, then, is where to get peptides online. Your choices are both many and few. Many because you’ll have no difficulty finding websites hawking dangerous nonprescription peptides intended for laboratory studies. Few because no human should use laboratory-designated peptides outside of a clinical research setting, and prescription channels are relatively scarce (more so ones with large catalogs and broad service areas).
But they’re out there. In fact, we’ve scoped the landscape and identified three reputable, widely available telehealth platforms with broad treatment catalogs. See our summary of recommendations directly below for the rundown. Then read further to see how we made our selections, as well as to better gauge whether you might be a candidate for peptide therapy.
Because peptides encompass such a wide range of treatments, and individuals prioritize different qualities in the telehealth platforms they seek, it wouldn’t be reasonable for us to designate a “best overall” telehealth platform in this guide.
Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions about staying healthy and living healthier lifestyles.
Therapeutic peptides have occupied our interest for years. Our research and writing on the subject now exceed 1,000 hours’ worth of effort. That doesn’t include all of the discussions we’ve had with prescribers and patients, either, which have provided us a ground-level view of what it’s like to actually use peptides. And as time goes on, we learn increasingly more about peptides as both a medical treatment and an industry, such that by the time you read this, our total clock time in this space may be double our current, conservative measure.
Additionally, like all health-related content on this website, this guide was thoroughly vetted by one or more members of our Medical Review Board for accuracy and will continue to be monitored for updates by our editorial team.
Surveying the landscape, we felt that to qualify as one of the best online peptide resources, a provider must be maximally accessible, provide optimal patient care, offer a wide range of treatment options, and minimize cost.
Our three recommended providers excel in almost every way, but one rises above the others in each category.
Advantage: Extension Health
Location availability was our lead consideration behind our recommendations because we want to point people to providers that can reach the largest possible audience. Therefore, to build a foundation for our list, we focused only on those that serve at least 40 U.S. territories, and relegated otherwise promising options to also-ran status.
Extension Health, then, was the clear winner because it serves 50 states, and there’s no beating 100% national coverage.
But our other recommendations aren’t far behind. At this time, Eternity Health Partners serves 45 states, and Bridgeside Telehealth serves 44. Keep in mind, too, that telehealth providers are constantly expanding or restricting their coverage areas. Eventually, Eternity and Bridgeside may catch up with Extension, Extension might fall behind, or all three will be overtaken by another provider altogether.
Advantage: Eternity Health Partners
In assessing the quality of therapeutic peptide providers, we considered it a requirement that providers meet baseline criteria for ensuring patient safety:
All of our recommendations meet these criteria, but only Eternity Health Partners goes a step further by requiring lab testing before consultation. It’s a big step, at that, because it reveals health issues and potential contraindications that clinicians can use to validate a patient’s candidacy and guide treatment.
That isn’t to say that Extension and Bridgeside won’t request lab testing at any point, but that testing isn’t necessarily built into their processes.
Advantage: Bridgeside Telehealth
In the peptide space, reaching the widest possible audience entails offering treatments that meet the broadest range of needs. Among our top recommendations, Bridgeside Telehealth excels in that regard, with at least 29 unique peptide therapies, including stacks. In addition to GLP-1 receptor agonists for weight loss, its catalog includes individual peptides and stacks for stress, cognition, sexual health, physical fitness, and longevity.
In fairness, Extension and Eternity have pretty packed catalogs themselves, with at least 26, and we can’t discount the possibility they’ll add more as time goes on. For now, though, Bridgeside stands above them.
Here’s a table for a side-by-side comparison:
| Bridgeside | Extension | Eternity | |
|---|---|---|---|
| AOD-9604 | |||
| AOD-9604 + MOTS-c | |||
| AOD-9604 + MOTS-c + tesamorelin | |||
| BPC-157 | |||
| BPC-157 acetate (oral) | |||
| BPC-157 + TB500 | |||
| BPC-157 + KPV + TB500 | |||
| BPC-157 + GHK-Cu + KPV + TB500 | |||
| Cerebrolysin | |||
| CJC-1295 + ipamorelin | |||
| DSIP | |||
| DSIP + pinealon | |||
| DSIP + BPC-157 + CJC-1295 | |||
| Epitalon | |||
| GHK-Cu | |||
| GHK-Cu + epitalon | |||
| IGF-1 (LR3) | |||
| Ipamorelin | |||
| Kisspeptin | |||
| KPV | |||
| LL37 | |||
| Melanotan II | |||
| MIC | |||
| MK-677 | |||
| MOTS-c | |||
| Pentosan PPS | |||
| Pinealon + PE-22-28 + Selank | |||
| PT-141 | |||
| PT-141 + oxytocin | |||
| PTD-DMB | |||
| Rapamycin + GHK-Cu | |||
| Retatrutide | |||
| Semaglutide | |||
| Semax | |||
| Selank | |||
| Selank + PE-22-28 | |||
| Sermorelin | |||
| SLU-PP-332 | |||
| SS-31 | |||
| Tesamorelin | |||
| Tesamorelin + ipamorelin | |||
| Tesofensine | |||
| Thymosin alpha-1 | |||
| Thymosin beta-4 | |||
| Tirzepatide |
Advantage: Bridgeside Telehealth
Peptides themselves are pricey, and variations in their costs are slight, but individual peptide providers may differ appreciably in their pricing. Bridgeside Telehealth especially stands out in this regard, as its $50 consultation fee presents the lowest barrier to entry among its competitors. Moreover, the fee is refunded to anyone who doesn’t qualify for treatment, so it’s a low-risk deposit.
Extension and Eternity are much more costly up front. Extension’s consultation costs $250 and is nonrefundable, while Eternity requires lab testing for most prospective patients, which costs at least several hundred dollars.
A good peptide telehealth service is like any quality healthcare provider. They:
In our survey of the landscape, we’ve found that these characteristics manifest in the following ways.
“Pharmaceutical-grade” refers to the quality of being suitable for human consumption. You might also see terms like “medical-grade” and “USP-grade,” which effectively mean the same thing.
More specifically, “pharmaceutical-grade” is a designation placed on a medical substance that conforms with strict standards of purity and potency. They come from facilities registered with the U.S. Food & Drug Administration (FDA) under current Good Manufacturing Practice (cGMP), which requires supplier validation, a sterile production environment, real-time documentation, end-to-end materials tracking, and testing.2 Such practices prevent the use of poor-quality components, minimize the risk of product contamination, and enhance traceability in the event that the end product comes out below standard.
To put it another way: a pharmaceutical-grade peptide is like a dish at a restaurant where all of the vendors are vetted, the produce is inspected, the chefs taste as they go, and everyone upholds a spirit of accountability when things go awry. Going in, you can expect a high level of satisfaction.
Trustworthy telehealth providers always begin their patient–provider relationships with a consultation, in which a licensed clinician evaluates your candidacy for a peptide prescription.
The consultation is as much a screening-out as a screening-in. No medically responsible clinician should approve you for a peptide by default. They ought to take a comprehensive medical history to determine whether you’re truly indicated for treatment, and if you are, they should recommend a starting dose and protocol that align with both your needs and your physical capacity. The most thorough telehealth platforms may even have you undergo biomarker testing to confirm your candidacy and possibly uncover concerns that haven’t been recorded in your medical record.
They should also be transparent about the potential risks of certain therapeutic peptides. Compared to GLP-1 receptor agonists (RAs) like Ozempic, which by now have been validated in numerous clinical trials, most peptides have substantially less research supporting their safety.3 At the very least, a good clinician will make you aware of the possible adverse effects, serious and otherwise, and instruct you on indicators for adjusting or discontinuing your treatment.
Whether or not you see results from your initial round of peptide treatment, you’ll want ongoing consultation with a clinician to dial in your dose, help you deal with side effects, answer questions, and address other concerns. That’s to say, you’ll want follow-ups, the frequency of which can shape patient satisfaction and lead to improved health outcomes.4 5
The nature of telehealth makes ongoing care theoretically more convenient than traditional face-to-face treatment, but the timeliness of communication ultimately depends on the individual clinician. Likely, your clinician will be a regional doctor contracted with a telehealth provider, someone who has added an online workload to their usual in-person practice, so you may need to make some allowances for their busy schedule. That being said, the best telehealth providers we’ve reviewed (in- and outside of the peptide space) have tended to yield prompt responses from clinicians.
For our purposes, we can regard telehealth as a form of e-commerce, and many of the best online businesses recognize that e-commerce is somewhat of a gamble for consumers. To soften the risk, they might offer certain assurances. There might be a refundable consultation, for example, or maybe a trial period. In some cases, you can pay for your treatment with an HSA/FSA, which can yield tax savings.
Additional assurances come simply in the form of a provider’s website copy that openly notes compliance with federal regulations and cGMP standards. It might speak of licensed compounding pharmacies, third-party testing, and certifications (e.g., LegitScript), as well as list contracted clinicians. These proofs of compliance and licensing, though they should be a given, are nice to have in case you were wondering about a provider’s legitimacy.
Illegitimate peptide providers are those that do not deal in pharmaceutical-grade peptides. They’re often easy to spot by naming conventions alone, as they typically style themselves after a “science-y” vibe (e.g., BioTech Pharmaceuticals, or something) or else include the word “peptide” itself (e.g., Next Gen Peptides, et al.).
But the most obvious red flag — a flag so big that you’d need a whole color guard to carry it — is that they do not require a prescription to purchase a peptide. Remember, the peptides we’re talking about aren’t over-the-counter goods but medical-strength drugs, and as such, they require medical oversight. No medical oversight equals no-go.
Invariably, if you click through the pages of a prescription-less peptide provider, you’ll see that each product is labeled either:
Which indicates that you’re looking at research-grade, not pharmaceutical-grade, peptides.
Research-grade peptides are easy to obtain, so the only thing stopping you from using them in your own body is a willingness to risk your health. We sincerely hope you lack such willingness. No matter how closely you hew to “safe” practices, research-grade peptides are inherently more dangerous than their prescription counterparts because they aren’t subject to the same production and purity standards. Indeed, a research-grade peptide can have a purity as low as 60%, as opposed to the >98% threshold for human use.6
Part of the impurity quotient constitutes bacterial endotoxins, the risks of which range from uncomfortable (fever, aches) to life-threatening (septic shock).7 And a higher proportion of impurities altogether increases the risk that the peptide could trigger an immunogenic response, in which the body perceives the drug as an invasive threat.8 In immunogenicity, the best you can hope for is that your immune system neutralizes the peptide and renders null its effects; the more severe alternative is that you could succumb to anaphylactic shock.9
All of that’s bad enough, but bear in mind also that if a provider isn’t dealing in prescription peptides, neither are they subject to the other standards that ensure consumer safety: traceable production, third-party testing, the use of licensed pharmacies, and clinical management of your treatment. When you buy from such a provider, you also assume the responsibility for any adverse events that arise.
Online peptides are generally safe as long as you purchase them through a legitimate, licensed, clinical provider, such as those we highlight in this guide. Not only are their peptides of the highest possible purity, but their consultations and ongoing care serve as safeguards against contraindications and adverse events.
The same general safety doesn’t necessarily apply to individual peptide treatments. Depending on the peptide you’re prescribed, it could pose some risks:
Therapeutic peptides are also known to cause less severe adverse effects in the short term. Most frequently, these are injection site reactions and mild flu-like symptoms.
Telehealth, in general, is a convenient healthcare channel for anyone who can’t or would rather not visit a doctor in person. That includes but isn’t limited to people who:
For peptides specifically, the ideal candidate would be someone with an indicated health concern, such as diabetes or obesity (for a GLP-1 RA), cognitive dysfunction (for a nootropic peptide), chronic stress (for an anxiolytic peptide), and so on. But even if you aren’t certain that you’re a good candidate, a telehealth appointment presents a relatively seamless way to get a clinician’s opinion on your suitability. You’ll just want to be sure to go with a provider that offers a refundable consultation in case you don’t qualify for treatment.
On the other hand, there are some populations for whom a telehealth-based peptide therapy probably wouldn’t be worth considering. Scared of needles, for instance? Unless you overcome your fear, you won’t be able to use most of the medicines that providers have to offer. Distrustful of experimental treatments? Many non-GLP-1 peptides could be classified as such. Or have a poor internet connection? That’ll certainly present a challenge in videoconferencing with your clinician, so an in-person appointment with your doctor would be a better option.
Medical contraindications disqualify you for treatment, too. Your clinician is responsible for noting exclusion criteria during your consultation, but you can save yourself the time by screening yourself out in advance. If you have a history of cancer, for example, you’d probably not be a candidate for any growth hormone secretagogue, given the risk of carcinogenicity.
Most location access
Extension Health is the only telehealth peptide provider we’ve found, so far, that serves all 50 states. It’s also the only one we know that gives patients the option to choose between pre-mixed peptides and unreconstituted powders, a convenience measure that should reassure anyone wary about fouling up the preparation of their medicine.
Extension’s catalog currently consists of 26 distinct peptide treatments, the same as Eternity Health Partners. These are:
You’ll notice that five of the options are non-injectable, which extends the viable audience to people with a needle phobia.
Most treatments are $300 per monthly shipment, though some (tirzepatide, MOTS-C) cost $750–$850. It’s pricier than, say, Bridgeside, which typically provides six-week supplies for around $300. That’s before adding $60–$80 for shipping.
Extension’s consultation fee is a sore point, too, as it costs $250 and is nonrefundable. Still, with its nationwide service area and wide range of treatments, it’s an excellent option for many people.
Most comprehensive care
Eternity’s distinguishing characteristic is the lengths it goes to ensure patient safety. For every prospective patient, screening begins with mandatory lab testing — a blood panel measuring around 20 biomarkers — that provides the clinician with a comprehensive set of data on which to determine one’s candidacy. The lab testing also guides treatment for the qualifying patient, as it can help determine which peptides are appropriate and how high a dose they need. The downside is that it increases the patient's up-front cost. Some peptides are eligible for a complimentary 15-minute pre-consult (in which a service team member explains the ins and outs of Eternity’s process), but everyone has to pay the price for testing eventually.
Like Extension, Eternity has a catalog of 26 distinct treatments, though the specific options differ significantly. In fact, Eternity’s offers peptides that are rarely found in other catalogs, including those of our other recommendations:
So, if you’re seeking a novel treatment for weight loss (AOD-9604, SLU-PP-332, tesofensine), cognitive health (cerebrolysin), muscle growth (IGF-1, MK-677), or hair growth (PTD-DBM), Eternity has a definite edge on Extension and Bridgeside.
As for pricing, Eternity is less transparent than Extension, but we learned through a customer support representative that most options in the catalog cost $350 per month’s supply. That isn’t much higher compared to competitors, but significant enough to consider.
Largest peptide catalog, most affordable
Bridgeside stands out in the peptide telehealth landscape for its larger-than-usual peptide catalog and its low up-front patient cost.
As of this writing, Bridgeside’s catalog numbers 29 distinct peptide treatments, many of which are stacks:
We consider the stacks to be unique treatments because combination therapies can potentially yield synergistic effects that monotherapies don’t. Also, a stack gives you the synergistic effect without your having to order multiple peptides at once, saving you money in the long run.
Speaking of money, let’s talk about that low up-front cost. Bridgeside, unlike Extension and Eternity, conducts a refundable consultation. If you don’t qualify for treatment, you get your money back. The consultation fee itself is the lowest in this guide, at just $50, and qualifying patients have it put toward their first peptide purchase (which, typically delivered in six-week supplies for around $300, ought to be less expensive than Extension).
For all that, though, we wish Bridgeside would update its website, which is sparse on the details of its treatment process. We’d also like its service area to be wider, although 44 states is still very good, and it may expand with time.
Sources
Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Fiore, K. (2026). RFK Jr. says FDA will lift ban on peptides. MedPage Today.
Electronic Code of Federal Regulations. (2026). Part 211—Current Good Manufacturing Practice for Finished Pharmaceuticals. eCFR.
Bartholomew, R. (2026). What's behind the peptide craze? Psychology Today.
Price, M. E., Done, N., & Pizer, S. D. (2020). The relationship between follow-up appointments and access to primary care. Journal of General Internal Medicine, 35(6), 1678-1683.
Khazen, M., et al. (2025). Responsibility of follow-up regarding medical recommendations in primary care and challenging patients: The perspective of doctors, nurses, pharmacists, and administrative staff. Patient Education and Counseling, 130, 108456.
De Groot, A. S., et al. (2023). Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discovery Today, 28(10), 103714.
Clegg, R., & Walker, A. (2026). Wellness peptide craze: Why people are injecting drugs 'not for human consumption'. BBC.
Mitra, M. S., et al. (2020). Development of peptide therapeutics: A nonclinical safety assessment perspective. Regulatory Toxicology and Pharmacology, 117, 104766.
Smith, C. M., et al. (2011). Novel immunogenic peptides elicit systemic anaphylaxis in mice: Implications for peptide vaccines. Journal of Immunology, 187(3), 1201-1206.
U.S. Food & Drug Administration. (2025). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA.
Cianfarani, S. (2019). Risk of cancer in patients treated with recombinant human growth hormone in childhood. Annals of Pediatric Endocrinology & Metabolism, 24(2), 92-98.
National Academies of Sciences, Engineering, and Medicine, et al. (2020). The clinical utility of compounded bioidentical hormone therapy: A review of safety, effectiveness, and use: Regulatory framework for compounded preparations. National Academies Press.
Regulatory Affairs Professionals Society. (2026). FDA considers adding a dozen peptides to its bulk drug compounding list. RAPS.
Jensen, K. (2026). FDA moves toward easing restrictions on certain peptides. BioPharmaDive.